Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer

por Choi, Cheolwon, Kwon, Junyeob, Lim, Sunyoung, Helfman, David M.
Publicado 2016

Loss of Tpm4.1 leads to disruption of cell-cell adhesions and invasive behavior in breast epithelial cells via increased Rac1 signaling

por Jeong, SukYeong, Lim, SunYoung, Schevzov, Galina, Gunning, Peter W., Helfman, David M.
Publicado 2017